ScholarIQanswers from OpenAlex & ORCID
Elizabeth R. Plimack
ResearcherPublications, citations & collaboration network
Elizabeth R. Plimack is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Elizabeth R. Plimack have?
ScholarIQindexed works
Elizabeth R. Plimack has 775 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Elizabeth R. Plimack have?
ScholarIQcitation count
Elizabeth R. Plimack has 49,597 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Elizabeth R. Plimack?
ScholarIQh-index
Elizabeth R. Plimack has an h-index of 80 in OpenAlex.
What is the i10-index of Elizabeth R. Plimack?
ScholarIQi10-index
Elizabeth R. Plimack has an i10-index of 257 in OpenAlex.
What is the ORCID of Elizabeth R. Plimack?
ScholarIQorcid
The ORCID for Elizabeth R. Plimack is on the source record.
What is the OpenAlex record for Elizabeth R. Plimack?
ScholarIQopenalex
The OpenAlex for Elizabeth R. Plimack is on the source record.
What are the most-cited papers on Elizabeth R. Plimack?
ScholarIQmost cited works
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Nizar M. Tannir, Ray McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Toni K. Choueiri, Elizabeth R. Plimack, Philippe Barthélémy, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Victoria Neiman, Christian Kollmannsberger, Pamela Salman, Howard Gurney, Robert D. Hawkins, Alain Ravaud, Marc‐Oliver Grimm, Sergio Bracarda, Carlos H. Barrios, Yoshihiko Tomita, Daniel Castellano, Brian I. Rini, Allen C. Chen, Sabeen Mekan, M. Brent McHenry, Megan Wind‐Rotolo, Justin Doan, Padmanee Sharma, Hans J. Hammers, Bernard Escudier
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D’Amico, Brian J. Davis, Tanya B. Dorff, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Joseph E. Ippolito, Christopher J. Kane, Michael Kuettel, Joshua M. Lang, Jesse K. McKenney, George J. Netto, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, Thomas J. Pugh, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ahmad Shabsigh, Eric J. Small, Daniel E. Spratt, Sandy Srinivas, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Noah M. Hahn, Daniel H. Shevrin, Robert Dreicer, Maha Hussain, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Nicholas J. Vogelzang, Joel Picus, Matthew M. Cooney, Jorge A. García, Robert S. DiPaola, Christopher J. Sweeney
Prostate Cancer
James L. Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony V. D’Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric M. Horwitz, Robert P. Huben, Philip W. Kantoff, Mark H. Kawachi, Michael Kuettel, Paul H. Lange, Gary R. MacVicar, Elizabeth R. Plimack, Julio M. Pow‐Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh